Pharmaceutically active combination

Details Pharmaceutically active combination Pharmaceutically active combination

1989-09-18

1992-06-30

Stone, Jacqueline

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424 9463, 514 2, 514 12, A61K 37547, A61K 3702

Patent

active

051261340

ABSTRACT:
There is provided a pharmaceutical composition comprising as component A a plasminogen activator and as component B hirudin together with a pharmaceutically acceptable carrier. The pharmaceutical composition can be used for the prophylaxis and therapy of thrombosis or diseases caused by thrombosis.

REFERENCES:
patent: 4801576 (1989-01-01), Fritz et al.
patent: 4944943 (1990-07-01), Eschenfelder et al.
J. M. Stassen et al., F. K. Schattauer Verlag (Stuttgart) 58(3) 947-950 (1987)-Thromb. Haemost.
F. Markwardt, Cardiovascular Pharmacology (1987) J. Gy. Papp (ed)-pp. 449-456.
Tamao et al., Thrombosis and Haemostasis 56(1), 28-34, (1986).
Markwardt et al., Thrombosis and Haemostasis 47(3), 226-229 (1982).
Rijken et al., Bioichem. J. (1986), 238, 643-646.
Van Zonneveld et al., J. Cell. Biochem. 32:169-178 (1986).
Ehrlich et al., Fibrinolysis, vol. 1, No. 2 (1987) pp. 75-82.
Haber et al., Science, vol. 243 (Jan. 6, 1989), pp. 51-56.

Affiliated with

Also associated with

Rating

Pharmaceutically active combination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically active combination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active combination will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1862481